A detailed history of Quent Capital, LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Quent Capital, LLC holds 16 shares of ALNY stock, worth $3,892. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16
Previous 16 -0.0%
Holding current value
$3,892
Previous $3,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 08, 2024

SELL
$143.31 - $247.0 $22,213 - $38,285
-155 Reduced 90.64%
16 $3,000
Q1 2024

May 02, 2024

SELL
$146.51 - $198.2 $293 - $396
-2 Reduced 1.16%
171 $25,000
Q4 2023

Jun 14, 2024

BUY
$151.41 - $196.57 $18,623 - $24,178
123 Added 246.0%
173 $33,000
Q4 2023

Jan 19, 2024

BUY
$151.41 - $196.57 $18,623 - $24,178
123 Added 246.0%
173 $33,000
Q3 2023

Jun 14, 2024

SELL
$170.77 - $211.65 $1,366 - $1,693
-8 Reduced 13.79%
50 $8,000
Q3 2023

Oct 10, 2023

SELL
$170.77 - $211.65 $1,366 - $1,693
-8 Reduced 13.79%
50 $8,000
Q1 2023

Jun 14, 2024

SELL
$182.66 - $235.53 $20,640 - $26,614
-113 Reduced 66.08%
58 $11,000
Q1 2023

Apr 05, 2023

BUY
$182.66 - $235.53 $9,133 - $11,776
50 Added 625.0%
58 $11,000
Q4 2022

Jan 19, 2023

BUY
$185.53 - $241.31 $1,484 - $1,930
8 New
8 $0

Others Institutions Holding ALNY

About ALNYLAM PHARMACEUTICALS, INC.


  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $29.9B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Quent Capital, LLC Portfolio

Follow Quent Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quent Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quent Capital, LLC with notifications on news.